Your account is not claimed yet. You can sign up with ORCID to claim your account.

Girolamo Pelaia

ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 36

Top Venues

Journal of clinical medicine

Therapeutic advances in respiratory disease

Biomedicines

Genes

Magna Graecia University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Magna Graecia University Aug 17o 2018

Italy

Professor of Respiratory Medicine :: Department of Medical and Surgical Sciences

Publications

Marco Caminati, Alessandro Marcon, Gabriella Guarnieri, Jessica Miotti, Diego Bagnasco, Giovanna Elisiana Carpagnano, Girolamo Pelaia, Rachele Vaia, Matteo Maule, Andrea Vianello, Gianenrico Senna
Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective. Journal of clinical medicine 12 (5) (2023)
Corrado Pelaia, Giada Procopio, Fioramante Lello Rotundo, Maria Rosaria Deodato, Anna Ferrante Bannera, Francesco Giuseppe Tropea, Anna Cancelliere, Alessandro Vatrella, Girolamo Pelaia
Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease. Therapeutic advances in respiratory disease 17 (2023)
Giulia Scioscia, Pasquale Tondo, Santi Nolasco, Corrado Pelaia, Giovanna Elisiana Carpagnano, Maria Filomena Caiaffa, Giuseppe Valenti, Angelantonio Maglio, Francesco Papia, Massimo Triggiani, Nunzio Crimi, Girolamo Pelaia, Alessandro Vatrella, Maria Pia Foschino Barbaro, Claudia Crimi
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience. Journal of clinical medicine 12 (13) (2023)
Corrado Pelaia, Giada Procopio, Fioramante Lello Rotundo, Maria Rosaria Deodato, Anna Ferrante Bannera, Francesco Giuseppe Tropea, Anna Cancelliere, Alessandro Vatrella, Girolamo Pelaia
Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease. Therapeutic advances in respiratory disease 17 (2023)
Fabiana Furci, Giuseppe Murdaca, Corrado Pelaia, Egidio Imbalzano, Girolamo Pelaia, Marco Caminati, Alessandro Allegra, Gianenrico Senna, Sebastiano Gangemi
TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD. Biomedicines 11 (2) (2023)
Corrado Pelaia, Giuseppe Armentaro, Chiara Lupia, Antonio Maiorano, Nicola Montenegro, Sofia Miceli, Valentino Condoleo, Velia Cassano, Andrea Bruni, Eugenio Garofalo, Claudia Crimi, Alessandro Vatrella, Girolamo Pelaia, Federico Longhini, Angela Sciacqua
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension. Journal of clinical medicine 12 (17) (2023)
Corrado Pelaia, Anna Ferrante Bannera, Fioramante Lello Rotundo, Francesco Giuseppe Tropea, Giuseppe Armentaro, Angelantonio Maglio, Angela Sciacqua, Alessandro Vatrella, Girolamo Pelaia
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study. International journal of chronic obstructive pulmonary disease 18 (2023)
Raffaele Campisi, Santi Nolasco, Corrado Pelaia, Pietro Impellizzeri, Maria D'Amato, Andrea Portacci, Luisa Ricciardi, Giulia Scioscia, Nunzio Crimi, Nicola Scichilone, Maria Pia Foschino Barbaro, Girolamo Pelaia, Giovanna Elisiana Carpagnano, Alessandro Vatrella, Claudia Crimi, null null
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study. Journal of clinical medicine 12 (12) (2023)
Giovanna Lucia Piazzetta, Nadia Lobello, Emanuela Chiarella, Alberta Rizzuti, Corrado Pelaia, Girolamo Pelaia, Nicola Lombardo
Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab. Journal of personalized medicine 13 (9) (2023)
Raffaele Campisi, Santi Nolasco, Corrado Pelaia, Pietro Impellizzeri, Maria D'Amato, Andrea Portacci, Luisa Ricciardi, Giulia Scioscia, Nunzio Crimi, Nicola Scichilone, Maria Pia Foschino Barbaro, Girolamo Pelaia, Giovanna Elisiana Carpagnano, Alessandro Vatrella, Claudia Crimi, null null
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study. Journal of clinical medicine 12 (12) (2023)
Marco Caminati, Alessandro Marcon, Gabriella Guarnieri, Jessica Miotti, Diego Bagnasco, Giovanna Elisiana Carpagnano, Girolamo Pelaia, Rachele Vaia, Matteo Maule, Andrea Vianello, Gianenrico Senna
Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective. Journal of clinical medicine 12 (5) (2023)
Fabiana Furci, Giuseppe Murdaca, Corrado Pelaia, Egidio Imbalzano, Girolamo Pelaia, Marco Caminati, Alessandro Allegra, Gianenrico Senna, Sebastiano Gangemi
TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD. Biomedicines 11 (2) (2023)
Fabiana Furci, Giuseppe Murdaca, Corrado Pelaia, Egidio Imbalzano, Girolamo Pelaia, Marco Caminati, Alessandro Allegra, Gianenrico Senna, Sebastiano Gangemi
TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD. Biomedicines 11 (2) (2023)
Carmen Spaccarotella, Alberto Polimeni, Cinzia Mancuso, Girolamo Pelaia, Giovanni Esposito, Ciro Indolfi
Assessment of Non-Invasive Measurements of Oxygen Saturation and Heart Rate with an Apple Smartwatch: Comparison with a Standard Pulse Oximeter. Journal of clinical medicine 11 (6) (2022)
Selena Mimmi, Nicola Lombardo, Domenico Maisano, Giovanna Piazzetta, Corrado Pelaia, Girolamo Pelaia, Marta Greco, Daniela Patrizia Foti, Vincenzo Dattilo, Enrico Iaccino
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence. Genes 13 (12) (2022)
Selena Mimmi, Nicola Lombardo, Domenico Maisano, Giovanna Piazzetta, Corrado Pelaia, Girolamo Pelaia, Marta Greco, Daniela Patrizia Foti, Vincenzo Dattilo, Enrico Iaccino
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence. Genes 13 (12) (2022)
Selena Mimmi, Nicola Lombardo, Domenico Maisano, Giovanna Piazzetta, Corrado Pelaia, Girolamo Pelaia, Marta Greco, Daniela Patrizia Foti, Vincenzo Dattilo, Enrico Iaccino
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence. Genes 13 (12) (2022)
Veronica Seccia, Maria D'Amato, Giulia Scioscia, Diego Bagnasco, Federico Raimondi, Gianluca Fadda, Francesco Menzella, Ernesto Pasquini, Girolamo Pelaia, Eugenio Tremante, Eugenio De Corso, Matteo Bonini
Management of Patients with Severe Asthma and Chronic Rhinosinusitis with Nasal Polyps: A Multidisciplinary Shared Approach. Journal of personalized medicine 12 (7) (2022)
Selena Mimmi, Nicola Lombardo, Domenico Maisano, Giovanna Piazzetta, Corrado Pelaia, Girolamo Pelaia, Marta Greco, Daniela Patrizia Foti, Vincenzo Dattilo, Enrico Iaccino
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence. Genes 13 (12) (2022)
Selena Mimmi, Nicola Lombardo, Domenico Maisano, Giovanna Piazzetta, Corrado Pelaia, Girolamo Pelaia, Marta Greco, Daniela Patrizia Foti, Vincenzo Dattilo, Enrico Iaccino
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence. Genes 13 (12) (2022)
Gianenrico Senna, Maria Aliani, Elena Altieri, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Paolo Cameli, Giorgio Walter Canonica, Cristiano Caruso, Maria D'Amato, Fausto De Michele, Stefano Del Giacco, Federico Raimondi, Francesco Menzella, Girolamo Pelaia, Rogliani Paola, Micaela Romagnoli, Pietro Schino, Jan Walter Schroeder, Alessandra Vultaggio, Sara Rizzoli, Alessandro Zullo, Silvia Boarino, Marilena Palmisano, Alessandra Rossi, Gianfranco Vitiello, Stefano Centanni
Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm<sup>3</sup>: A Post Hoc Analysis from the ANANKE Study. Journal of asthma and allergy 15 (2022)
Eugenio De Corso, Maria Beatrice Bilò, Andrea Matucci, Veronica Seccia, Fulvio Braido, Matteo Gelardi, Enrico Heffler, Manuela Latorre, Luca Malvezzi, Girolamo Pelaia, Gianenrico Senna, Paolo Castelnuovo, Giorgio Walter Canonica
Personalized Management of Patients with Chronic Rhinosinusitis with Nasal Polyps in Clinical Practice: A Multidisciplinary Consensus Statement. Journal of personalized medicine 12 (5) (2022)
Corrado Pelaia, Claudia Crimi, Alida Benfante, Maria Filomena Caiaffa, Cecilia Calabrese, Giovanna Elisiana Carpagnano, Domenico Ciotta, Maria D'Amato, Luigi Macchia, Santi Nolasco, Girolamo Pelaia, Simona Pellegrino, Nicola Scichilone, Giulia Scioscia, Giuseppe Spadaro, Giuseppe Valenti, Alessandro Vatrella, Nunzio Crimi
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression. Journal of asthma and allergy 14 (2021)
Corrado Pelaia, Nicola Lombardo, Maria Teresa Busceti, Giovanna Piazzetta, Claudia Crimi, Cecilia Calabrese, Alessandro Vatrella, Girolamo Pelaia
Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis. Journal of asthma and allergy 14 (2021)
Angelantonio Maglio, Carolina Vitale, Simona Pellegrino, Cecilia Calabrese, Maria D'Amato, Antonio Molino, Corrado Pelaia, Massimo Triggiani, Girolamo Pelaia, Cristiana Stellato, Alessandro Vatrella
Real-Life Effectiveness of Mepolizumab on Forced Expiratory Flow between 25% and 75% of Forced Vital Capacity in Patients with Severe Eosinophilic Asthma. Biomedicines 9 (11) (2021)
Corrado Pelaia, Alessandro Vatrella, Lucia Muraca, Nicola Lombardo, Angela Sciacqua, Rocco Savino, Girolamo Pelaia
Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies. Drug design, development and therapy 15 (2021)
Corrado Pelaia, Claudia Crimi, Santi Nolasco, Giovanna Elisiana Carpagnano, Raffaele Brancaccio, Enrico Buonamico, Raffaele Campisi, Claudia Gagliani, Vincenzo Patella, Girolamo Pelaia, Giuseppe Valenti, Nunzio Crimi
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy. Biomedicines 9 (12) (2021)
Giovanna Elisiana Carpagnano, Corrado Pelaia, Maria D'Amato, Nunzio Crimi, Nicola Scichilone, Giulia Scioscia, Onofrio Resta, Cecilia Calabrese, Girolamo Pelaia, Carla Maria Irene Quarato, Maria Pia Foschino Barbaro
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy. Therapeutic advances in respiratory disease 14 (2021)
Francesco Menzella, Marco Bonavia, Matteo Bonini, Maria D'Amato, Salvatore Lombardo, Nicola Murgia, Vincenzo Patella, Massimo Triggiani, Girolamo Pelaia
Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series. Journal of asthma and allergy 14 (2021)
Nicola Lombardo, Corrado Pelaia, Marco Ciriolo, Marcello Della Corte, Giovanna Piazzetta, Nadia Lobello, Pasquale Viola, Girolamo Pelaia
Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma. International journal of immunopathology and pharmacology 34 (2021)
Corrado Pelaia, Maria Teresa Busceti, Alessandro Vatrella, Marco Ciriolo, Eugenio Garofalo, Claudia Crimi, Rosa Terracciano, Nicola Lombardo, Girolamo Pelaia
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma. SAGE open medical case reports 8 (2020)
Giada Procopio, Anna Cancelliere, Enrico Maria Trecarichi, Maria Mazzitelli, Eugenio Arrighi, Graziella Perri, Francesca Serapide, Corrado Pelaia, Elena Lio, Maria Teresa Busceti, Maria Chiara Pelle, Marco Ricchio, Vincenzo Scaglione, Chiara Davoli, Paolo Fusco, Valentina La Gamba, Carlo Torti, Girolamo Pelaia
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study. Therapeutic advances in respiratory disease 14 (2020)
Corrado Pelaia, Caterina Tinello, Alessandro Vatrella, Giovambattista De Sarro, Girolamo Pelaia
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications. Therapeutic advances in respiratory disease 14 (2020)
Corrado Pelaia, Cecilia Calabrese, Rosa Terracciano, Francesco de Blasio, Alessandro Vatrella, Girolamo Pelaia
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness. Therapeutic advances in respiratory disease 12 (2019)
Corrado Pelaia, Cecilia Calabrese, Alessandro Vatrella, Maria Teresa Busceti, Eugenio Garofalo, Nicola Lombardo, Rosa Terracciano, Girolamo Pelaia
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma. BioMed research international 2018 (2018)
Girolamo Pelaia, Alessandro Vatrella, Maria Teresa Busceti, Luca Gallelli, Cecilia Calabrese, Rosa Terracciano, Rosario Maselli
Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma. Mediators of inflammation 2015 (2015)

Girolamo Pelaia.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Girolamo Pelaia